IGF1 and esophageal adenocarcinoma: Function-altering polymorphisms in IGF1R [13] as well as IGF1 microsatellite repeats and single strand nucleotide polymorphisms [14, 15] have been shown to affect risk for developing Barrett's esophagus and/or EAC.